Alkermes (ALKS) Free Cash Flow (2010 - 2026)
Alkermes (ALKS) recorded Free Cash Flow of $90.08 million in Q3 2026, up 6.8% from $84.36 million a year earlier but down 34.3% from the prior quarter.
Alkermes (ALKS) Free Cash Flow (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' Free Cash Flow came in at $227.37 million as of Sep 30, 2026, down 53.7% year-over-year; for FY2025, it was $480.33 million, up 18.4% from FY2024.
- Annual Free Cash Flow has a five-year compound annual growth rate of 63.9% (FY2020 to FY2025).
- Across earlier years, Free Cash Flow came in at $405.64 million in FY2024 (+14.8%), $353.31 million in FY2023, -$17.21 million in FY2022 and $73.7 million in FY2021 (+81.4%).
- Quarterly Free Cash Flow has ranged from -$169.83 million in Q1 2026 to $206.01 million in Q2 2023 over the past five years.
- On a year-over-year basis, Free Cash Flow rose in four of the last seven quarters, with growth averaging 101.4%.
- Peak year-over-year performance for Free Cash Flow in the last five years was growth of 594.8% in Q1 2025, against a decline of 63.9% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $137.04 million (Q2 2026), -$169.83 million (Q1 2026) and $170.09 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 8.22 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 7.31 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.52 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.96 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.65 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 4.80 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.80 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 90.08 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 90.08 Mn |
| Jun 30, 2026 | 137.04 Mn |
| Mar 31, 2026 | -169.83 Mn |
| Dec 31, 2025 | 170.09 Mn |
| Sep 30, 2025 | 84.36 Mn |
| Jun 30, 2025 | 137.19 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Dec 31, 2024 | 180.62 Mn |
| Sep 30, 2024 | 73.33 Mn |
| Jun 30, 2024 | 138.92 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Dec 31, 2023 | 90.21 Mn |
| Sep 30, 2023 | 85.26 Mn |
| Jun 30, 2023 | 206.01 Mn |
| Mar 31, 2023 | -28.16 Mn |
| Dec 31, 2022 | -8.98 Mn |
| Sep 30, 2022 | -9.85 Mn |
| Jun 30, 2022 | -12.27 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 22.36 Mn |
Alkermes Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();